Back to Search
Start Over
First-Line Pembrolizumab plus Axitinib Combination Boosts Survival in Metastatic Renal Cell Carcinoma.
- Source :
- Journal of Oncology Navigation & Survivorship; Aug2019, Vol. 10 Issue 8, p317-318, 2p
- Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 21660999
- Volume :
- 10
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Journal of Oncology Navigation & Survivorship
- Publication Type :
- Academic Journal
- Accession number :
- 137759380